TL;DR: A 2026 functional MRI (fMRI) study in Translational Psychiatry found that counterconditioning, a form of exposure learning that replaces a threat cue with a positive outcome, strengthened safety-memory signals in adults with PTSD more than standard extinction did. Key Findings Safety learning was tested: Researchers studied 54 adults, including 32 with post-traumatic stress disorder …
TL;DR: A 2025 study in Thinking & Reasoning found that twelfth graders outperformed seventh graders on fast probability reasoning, but adult-like logical intuition was still not fully developed by the end of high school. Key Findings More than 300 French students were tested: The study compared seventh graders around age 12 with twelfth graders around …
TL;DR: A 2026 npj Parkinson’s Disease study used brain transcriptome data and genome-scale metabolic modeling to predict Parkinson’s metabolite biomarkers, including dopamine-related changes, and separated 104 postmortem samples into three metabolic clusters. Key Findings Metabolic model: The study used TAMBOOR, a transcriptome-based metabolic modeling algorithm, to predict metabolite oversecretion and undersecretion. Brain tissue data: The …
TL;DR: A 2026 study in Personality and Individual Differences found that people higher in neuroticism reported more problem- and uncertainty-focused thoughts during blank-screen rest periods, which tracked with more unpleasant feelings. Key Findings Neuroticism was tested during idle thought: researchers used a blank-screen paradigm to sample what participants thought about when they had no task …
TL;DR: A 2026 preprint neurosurgery neuroplasticity study in medRxiv found that language-targeted prehabilitation selectively changed language-network topography, while language and cognitive performance were preserved after the intervention. Key Findings Study type: a prehabilitation study using neuromodulation, language training, task-based functional MRI (fMRI), and neuropsychological testing. People studied: 26 patients with operable brain tumors affecting language …
TL;DR: A 2026 study in Drug Design, Development and Therapy validated liquid chromatography-tandem mass spectrometry (LC-MS/MS), a high-specificity lab method, to screen serum for 77 neuropsychiatric drugs and then applied it to 1,021 clinical specimens over 3 years. Key Findings 77 drugs screened: Researchers developed a serum LC-MS/MS method for simultaneous qualitative identification of neuropsychiatric …
TL;DR: A 2026 longitudinal pilot study in Psychosis from Yale recruited 20 adults with schizophrenia or distressing auditory hallucinations into 6 weeks of group songwriting and found reduced paranoia in less-severely affected participants plus a shift from self-focused first-person pronouns toward plural pronouns. Key Findings Group songwriting recruited adults with psychosis symptoms: 20 participants aged …
TL;DR: A 2026 study in The British Journal of Psychiatry found that in first-episode psychosis, MRI deviations from age-matched brain norms at illness onset helped predict which patients would carry heavier symptom burdens and poorer functioning for years afterward. Key Findings 100,000-scan reference model: Researchers used a lifespan normative MRI model built on more than …
TL;DR: A 2026 study in Nature Nanotechnology reported that printed MoS2 memristive nanosheet networks, electronic devices that can produce neuron-like spikes, triggered responses in living mouse brain slices. Key Findings Artificial spiking neurons: Researchers built printed MoS2 memristive nanosheet networks that generated electrical activity resembling neural spikes. Living-tissue response: In mouse brain-slice experiments, the artificial …
TL;DR: A 2026 mouse study in Proceedings of the National Academy of Sciences found that deleting or inhibiting PTP1B improved memory behavior, reduced amyloid-beta burden, and pushed microglia toward an amyloid-clearing state. Key Findings Memory behavior improved: APP/PS1 mice lacking PTP1B performed better in novel object recognition and Morris water maze tests; the PTP1B inhibitor …
